DK0797575T3 - Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinase - Google Patents
Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinaseInfo
- Publication number
- DK0797575T3 DK0797575T3 DK95941646T DK95941646T DK0797575T3 DK 0797575 T3 DK0797575 T3 DK 0797575T3 DK 95941646 T DK95941646 T DK 95941646T DK 95941646 T DK95941646 T DK 95941646T DK 0797575 T3 DK0797575 T3 DK 0797575T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidazole derivatives
- protein kinase
- tyrosine kinase
- kinase inhibitors
- especially egf
- Prior art date
Links
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 title 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 title 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH376894 | 1994-12-13 | ||
PCT/EP1995/004741 WO1996018626A1 (en) | 1994-12-13 | 1995-12-01 | Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0797575T3 true DK0797575T3 (da) | 2004-02-16 |
Family
ID=4263074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95941646T DK0797575T3 (da) | 1994-12-13 | 1995-12-01 | Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinase |
Country Status (16)
Country | Link |
---|---|
US (1) | US5959113A (da) |
EP (1) | EP0797575B1 (da) |
JP (1) | JPH10510281A (da) |
CN (1) | CN1145623C (da) |
AR (1) | AR003406A1 (da) |
AT (1) | ATE252094T1 (da) |
AU (1) | AU4301096A (da) |
BR (1) | BR9509998A (da) |
CA (1) | CA2207404C (da) |
DE (1) | DE69531956T2 (da) |
DK (1) | DK0797575T3 (da) |
ES (1) | ES2208698T3 (da) |
FI (1) | FI972492A0 (da) |
PT (1) | PT797575E (da) |
TR (1) | TR199501561A2 (da) |
WO (1) | WO1996018626A1 (da) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083949A (en) * | 1995-10-06 | 2000-07-04 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
AU728760B2 (en) * | 1996-11-20 | 2001-01-18 | Merck & Co., Inc. | Triaryl substituted imidazoles, compositions containing such compounds and methods of use |
WO1998022109A1 (en) * | 1996-11-20 | 1998-05-28 | Merck & Co., Inc. | Triaryl substituted imidazoles as glucagon antagonists |
US5880139A (en) * | 1996-11-20 | 1999-03-09 | Merck & Co., Inc. | Triaryl substituted imidazoles as glucagon antagonists |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
AU4506399A (en) * | 1998-06-05 | 1999-12-30 | Novartis Ag | Aryl pyridinyl thiazoles |
AU4395399A (en) * | 1998-07-02 | 2000-01-24 | Sankyo Company Limited | Five-membered heteroaryl compounds |
JP3850596B2 (ja) | 1999-02-25 | 2006-11-29 | 本州化学工業株式会社 | 新規な部分保護トリスフェノール類とその製造方法 |
WO2003024447A1 (en) * | 2001-09-20 | 2003-03-27 | Smithkline Beecham Corporation | Inhibitors of glycogen synthase kinase-3 |
US6790852B2 (en) * | 2002-04-18 | 2004-09-14 | Hoffmann-La Roche Inc. | 2-(2,6-dichlorophenyl)-diarylimidazoles |
ES2497116T3 (es) | 2002-08-19 | 2014-09-22 | Lorus Therapeutics Inc. | Imidazoles 2,4,5-trisustituidos y su uso como agentes antimicrobianos |
CN100436450C (zh) * | 2003-10-16 | 2008-11-26 | 霍夫曼-拉罗奇有限公司 | 三芳基咪唑 |
US7144889B2 (en) | 2003-10-16 | 2006-12-05 | Hoffman-La Roche Inc. | Triarylimidazoles |
US7169781B2 (en) * | 2003-10-17 | 2007-01-30 | Hoffmann-La Roche Inc. | Imidazole derivatives and their use as pharmaceutical agents |
AU2004289539C1 (en) | 2003-11-14 | 2012-06-07 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
KR100905678B1 (ko) * | 2005-02-18 | 2009-07-03 | 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 | 광학 활성 에폭시 화합물의 제조 방법, 및 상기 방법에사용하기 위한 착체 및 그의 제조 방법 |
US8148392B2 (en) | 2005-05-25 | 2012-04-03 | Lorus Therapeutics Inc. | 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer |
JP5283872B2 (ja) * | 2006-09-27 | 2013-09-04 | シスメックス株式会社 | 腫瘍細胞に対する阻害剤の増殖抑制効果を評価する方法、及び腫瘍細胞の増殖を阻害する化合物をスクリーニングする方法 |
WO2008042216A2 (en) * | 2006-09-28 | 2008-04-10 | Follica, Inc. | Methods, kits, and compositions for generating new hair follicles and growing hair |
JP2016516082A (ja) | 2013-03-20 | 2016-06-02 | アプトース バイオサイエンシーズ, インコーポレイテッド | 2−置換イミダゾ[4,5−d]フェナントロリン誘導体及び癌の治療におけるそれらの使用 |
DK3052102T3 (da) | 2013-10-04 | 2020-03-09 | Aptose Biosciences Inc | Sammensætninger til behandling af cancere |
US9394236B2 (en) | 2014-02-03 | 2016-07-19 | Quadriga Biosciences, Inc. | β-substituted γ-amino acids and analogs as chemotherapeutic agents |
SG10201710436WA (en) | 2014-02-03 | 2018-01-30 | Quadriga Biosciences Inc | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
ES2926931T3 (es) * | 2014-02-07 | 2022-10-31 | Agency Science Tech & Res | Inhibidores de caseína quinasa 1 basados en azoles 2,4,5-tri-sustituidos como inductores de la cardiomiogénesis |
TWI665178B (zh) | 2015-08-03 | 2019-07-11 | 夸德里加生物科學公司 | 作為化療劑的β-取代的β-氨基酸和類似物及其應用 |
CN109212045A (zh) * | 2017-07-04 | 2019-01-15 | 万全万特制药(厦门)有限公司 | 草酸艾司西酞普兰残留溶剂和杂质的分离测定方法 |
KR20200096914A (ko) | 2017-10-30 | 2020-08-14 | 압토스 바이오사이언시스 인코포레이티드 | 암 치료용 아릴 이미다졸 |
CN114262298B (zh) * | 2021-12-03 | 2023-09-26 | 郑州轻工业大学 | 2-溴-4-n,n-二甲氨基咪唑及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3707475A (en) * | 1970-11-16 | 1972-12-26 | Pfizer | Antiinflammatory imidazoles |
US3940486A (en) * | 1971-05-10 | 1976-02-24 | Ciba-Geigy Corporation | Imidazole derivatives in the treatment of pain |
CH561716A5 (da) * | 1971-05-10 | 1975-05-15 | Ciba Geigy Ag | |
MC2096A1 (fr) * | 1989-02-23 | 1991-02-15 | Hoffmann La Roche | Pyrroles substitues |
EP0624159B1 (en) * | 1992-01-13 | 1998-11-25 | Smithkline Beecham Corporation | Pyridyl substituted imidazoles |
MX9300141A (es) * | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
HUT71553A (en) * | 1992-08-06 | 1995-12-28 | Warner Lambert Co | 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
WO1995003297A1 (en) * | 1993-07-21 | 1995-02-02 | Smithkline Beecham Corporation | Imidazoles for treating cytokine mediated disease |
NZ274063A (en) * | 1993-09-17 | 1997-11-24 | Smithkline Beecham Corp | Cytokine suppressive anti-inflammatory drug binding protein (csbp) and its use |
-
1995
- 1995-12-01 EP EP95941646A patent/EP0797575B1/en not_active Expired - Lifetime
- 1995-12-01 ES ES95941646T patent/ES2208698T3/es not_active Expired - Lifetime
- 1995-12-01 US US08/860,750 patent/US5959113A/en not_active Expired - Fee Related
- 1995-12-01 BR BR9509998A patent/BR9509998A/pt not_active IP Right Cessation
- 1995-12-01 PT PT95941646T patent/PT797575E/pt unknown
- 1995-12-01 JP JP8518206A patent/JPH10510281A/ja not_active Ceased
- 1995-12-01 DE DE69531956T patent/DE69531956T2/de not_active Expired - Fee Related
- 1995-12-01 AU AU43010/96A patent/AU4301096A/en not_active Abandoned
- 1995-12-01 CN CNB951976281A patent/CN1145623C/zh not_active Expired - Fee Related
- 1995-12-01 DK DK95941646T patent/DK0797575T3/da active
- 1995-12-01 CA CA002207404A patent/CA2207404C/en not_active Expired - Fee Related
- 1995-12-01 WO PCT/EP1995/004741 patent/WO1996018626A1/en active IP Right Grant
- 1995-12-01 AT AT95941646T patent/ATE252094T1/de not_active IP Right Cessation
- 1995-12-11 AR ARP950100495A patent/AR003406A1/es unknown
- 1995-12-12 TR TR95/01561A patent/TR199501561A2/xx unknown
-
1997
- 1997-06-12 FI FI972492A patent/FI972492A0/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1175252A (zh) | 1998-03-04 |
DE69531956T2 (de) | 2004-07-29 |
FI972492A (fi) | 1997-06-12 |
JPH10510281A (ja) | 1998-10-06 |
CN1145623C (zh) | 2004-04-14 |
AU4301096A (en) | 1996-07-03 |
FI972492A0 (fi) | 1997-06-12 |
EP0797575A1 (en) | 1997-10-01 |
ES2208698T3 (es) | 2004-06-16 |
CA2207404C (en) | 2004-06-29 |
BR9509998A (pt) | 1997-12-30 |
US5959113A (en) | 1999-09-28 |
CA2207404A1 (en) | 1996-06-20 |
WO1996018626A1 (en) | 1996-06-20 |
DE69531956D1 (de) | 2003-11-20 |
ATE252094T1 (de) | 2003-11-15 |
AR003406A1 (es) | 1998-08-05 |
PT797575E (pt) | 2004-02-27 |
EP0797575B1 (en) | 2003-10-15 |
MX9704263A (es) | 1997-09-30 |
TR199501561A2 (tr) | 1996-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0797575T3 (da) | Imidazolderivater som proteinkinase-inhibitorer, især EGF-R-tyrosinkinase | |
NO20011575D0 (no) | Substituerte 3-cyanokinoliner som proteintyrosin-kinase- inhibitorer | |
NO20011574D0 (no) | Substituerte 3-cyanokinoliner som proteintyrosin-kinsase- inhibitorer | |
DK0912559T3 (da) | Kondenserede heterocykliske forbindelser som proteintyrosinkinaseinhibitorer | |
NO990123D0 (no) | Bicykliske heteroaromatiske forbindelser som protein-tyrosin-kinase-inhibitorer | |
NO990124D0 (no) | Bicykliske heteroaromatiske forbindelser som protein-tyrosin-kinase-inhibitorer | |
DE69511253D1 (de) | Wasserlösliche 3-arylidene-2-oxindole derivate als tyrosine kinase inhibitoren | |
DK1460072T3 (da) | Bicykliske heteroaromatiske forbindelser som proteintyrosinkinaseinhibitorer | |
ID30460A (id) | Inhibitor-inhibitor protein siklik tirosin kinase | |
DE69627179T2 (de) | Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren | |
ATE430149T1 (de) | Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren | |
ZA9810219B (en) | Benzothiazole protein tyrosine kinase inhibitors. | |
NO995695D0 (no) | Substituerte pyrazoler som p38-kinase-inhibitorer | |
DK1000039T3 (da) | Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer | |
AU2437900A (en) | Piperidinylquinolines as protein tyrosine kinase inhibitors | |
DK1500657T3 (da) | Substituerede pyrazoler som p38-kinaseinhibitorer | |
DK0858452T3 (da) | Thiazolderivater som proteinkinase C-inhibitorer | |
AU2396897A (en) | 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick | |
NO20021820L (no) | Tyrosinkinaseinhibitorer | |
NO20011356D0 (no) | Pyrrolopyrimidiner som proteinkinase-inhibitorer | |
ATE387448T1 (de) | 4,5-pyrazinoxindole als proteinkinasehemmer | |
ATE205836T1 (de) | Bicyclische 4-aralkylaminopyrimidin-derivate als tyrosinkinase-inhibitoren | |
NO20015062L (no) | Substituerte 3-cyano-[1.7],[1.5]og[1.8]-naftyridin- inhibitorer for tyrosin-kinaser |